Skip to content

Short-term effects of low-concentration atropine eye drops and myopic retinal defocus

Short-term effects of low-concentration atropine eye drops and myopic retinal defocus on choroidal thickness and choroidal blood flow

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1031240082
Enrollment
40
Registered
2024-05-14
Start date
2024-05-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

0.05% atropine ophthalmic drops.
Low-concentration atropine eye drops

Sponsors

Mastumura Saiko
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Normal myopic eyes (-0.50D to -10.0D) without ocular disease other than refractive error, aged 20 to 30 years

Exclusion criteria

Exclusion criteria: Patients with ocular diseases other than refractive error (requiring structural abnormalities such as trauma, retinal detachment, cataract, corneal scarring, etc.). Patients with a history of eye surgery. Patients with systemic diseases (diabetes, hypertension, circulatory system diseases). Those with a history of myopia control treatment.

Design outcomes

Primary

MeasureTime frame
choroidal blood flow and choroidal thickness

Secondary

MeasureTime frame
axial length

Contacts

Public ContactSaiko Mastumura

Toho University Omori Medical Center

saiko.matsumura@med.toho-u.ac.jp+81-3-3762-4151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026